MedPath

Effects of N-acetyl Cystein (NAC) Supplementation in G6PD Deficient Individuals After Acute Exercise

Early Phase 1
Conditions
G6PD Deficiency
Interventions
Drug: N-acetyl cystein
Other: Placebo
Registration Number
NCT02937376
Lead Sponsor
University of Thessaly
Brief Summary

The purpose of this study is to investigate the effects of N-acetyl Cystein (NAC) supplementation on redox status, physiological and biochemical parameters in G6PD deficient individuals after acute exercise.

Detailed Description

In a randomized double-blind, crossover design, 12 adult volunteers with G6PD deficiency of both sexes will be supplemented with either 10 mg/kg of NAC (experimental condition - EC) or placebo (control condition - CC) every day for 4 weeks. Before intervention, all participants will be informed about the study protocol, fill a medical history questionnaire and sign an informed consent form. Moreover, measurements of anthropometric characteristics and physiological parameters, as well as a VO2max test will be performed.

Participants will perform 4 trials of exercise (70% VO2max for 45min and 90% till exhaustion) before and after each condition. Blood samples will be collected before, immediately after and 1 hour after exercise. Moreover, measurements of anthropometric characteristics and physiological parameters will be performed before and after each condition. There will be a washout period of at 4 weeks between conditions.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
12
Inclusion Criteria
  • G6PD deficiency
Exclusion Criteria
  • Any uncontrolled health condition for which exercise is contraindicated
  • Current use of dietary supplements or drugs
  • Pregnant, pregnancy intention or breast feeding

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
N-acetyl CysteinN-acetyl cysteinNAC supplementation (10 mg/kg/day) for 4 weeks in a counterbalanced manner to 12 G6PD deficient individuals.
PlaceboPlaceboPlacebo administration for 4 weeks in a counterbalanced manner to 12 G6PD deficient individuals.
Primary Outcome Measures
NameTimeMethod
Change in redox status after exerciseBefore, immediately after and 1 hour after each trial of exercise

Indices of blood redox status

Secondary Outcome Measures
NameTimeMethod
Blood pressureBefore and after 4 weeks of NAC supplementation, before and after 4 weeks of placebo

Blood pressure at rest

Body compositionBefore and after 4 weeks of NAC supplementation, before and after 4 weeks of placebo

Body fat percentage

Trial Locations

Locations (1)

Department of Physical Education & Sport Science of the University of Thessaly

🇬🇷

Trikala, Karyes, Greece

© Copyright 2025. All Rights Reserved by MedPath